ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.

March 1, 2002

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008